[Effectiveness of amitetravite and adenosine triphosphoric acid in conditions of prolonged irradiation].
D000255:Adenosine Triphosphate / Q000627:therapeutic use*; D000596:Amino Acids / Q000627:therapeutic use*; D000818:Animals; D001205:Ascorbic Acid / Q000627:therapeutic use; D001772:Blood Cell Count; D001792:Blood Platelets; D004285:Dogs; D005419:Flavonoids / Q000627:therapeutic use; D006639:Histidine / Q000627:therapeutic use; D007958:Leukocyte Count; D011833:Radiation Injuries, Experimental / Q000188:drug therapy*; D011837:Radiation-Protective Agents / Q000627:therapeutic use*; D013997:Time Factors; D014364:Tryptophan / Q000627:therapeutic use; D014803:Vitamin B Complex / Q000627:therapeutic use; D014815:Vitamins / Q000627:therapeutic use*
D000596:Amino Acids; D005419:Flavonoids; D011837:Radiation-Protective Agents; D014815:Vitamins; D014803:Vitamin B Complex; D006639:Histidine; D014364:Tryptophan; D000255:Adenosine Triphosphate; D001205:Ascorbic Acid
Effektivnost' deĭstviia amitetravita ia adenozintrifosfornoĭ kisloty v usloviiakh prolongirovannogo oblucheniia.